Clinical Trial Update: Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate the role of microRNA-1 (miR-1) in disease pathogenesis and as a biomarker for muscular dystrophies and congenital myo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy
• Congenital Myopathies
• Duchenne Muscular Dystrophy
• Myotonic Dystrophy Type

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Duchenne / Becker Muscular Dystrophy, Dystrophia Myotonica 1 | NA | Status: RECRUITING